Healthcare Economics & Policy

The American College of Cardiology (ACC) announced the selection of Timothy W. Attebery, MBA, to serve as its chief executive officer, effective Sept. 1.
Boston Scientific announced its acquisition of Santa Rosa, California-based Claret Medical in a transaction that includes $220 million upfront and an additional potential reimbursement-based milestone payment of up to $50 million. The deal is expected to close before the end of the year.
As CMS revisits the procedural volume requirements for centers to start and maintain a transcatheter aortic valve replacement (TAVR) program, several professional societies argued for direct TAVR experience to factor more strongly into the new standards.
Individuals with the human immunodeficiency virus (HIV) are twice as likely to develop cardiovascular disease, according to a global analysis published on July 18 in the American Heart Association’s journal Circulation.
In an era of clinician shortages, those living in rural areas are at risk of not receiving needed care. Cardiologists are stepping up, but will it be enough?
July 16, 2018 | Hypertension
The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.
CMS proposed several changes to its Medicare billing standards July 12, including paying doctors for virtual visits and alleviating some of their administrative burden.
July 12, 2018 | Practice Management
A new survey from University of Utah Health revealed that most physicians feel responsible for educating patients about the cost of care but don’t believe they should be held accountable for it.
Valsartan, a common drug used to control hypertension and heart failure, is being recalled in 22 counties due to concerns its active pharmaceutical ingredient, N-Nitrosodimethylamine (NDMA), a known carcinogen, poses a cancer risk.
The U.S. Preventive Services Task Force (USPSTF) issued a Grade I recommendation for screening peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI), indicating current evidence is insufficient to recommend screening without signs or symptoms of disease.
Boston Scientific plans to acquire Cryterion Medical, a company developing a single-shot cryoablation platform to treat patients with atrial fibrillation (AFib). Already an investor in the company, Boston Scientific will purchase the remaining 65 percent stake for $202 million in up-front cash.
A federal investigation into the potential overuse of primary prevention implantable cardioverter defibrillators (ICDs) appears to have made hospitals more judicious in their use of the devices, according to a study published July 3 in the Journal of the American Medical Association.
Health insurance does little to protect low-income families from crippling financial hardship when a relative has atherosclerotic cardiovascular disease (ASCVD), according to a study published July 3 in JAMA Cardiology.
The FDA’s rules preventing sexually active gay men from donating blood are discriminatory and based on outdated fears, a physician wrote in an op-ed piece for the Los Angeles Times.
CMS is taking public comments ahead of a Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) meeting July 25 in which panelists will discuss procedural volume requirements for centers to begin and maintain a transcatheter aortic valve replacement (TAVR) program.
A company called Novoheart has created the first 3D heart organoid—a miniature version of the real thing—which contains a hollow chamber similar to one of the four in a normal human heart. According to a story published by Wired, these mini-hearts could be used to test the effects of drug treatments before expensive human trials are necessary.
Healthcare Economics & Policy
Safety-net hospitals (SNHs) and smaller facilities were less likely to participate in the voluntary Bundled Payments for Care Improvement (BPCI) programs for cardiac services than larger centers with catheterization laboratories. These findings indicate that the outcomes observed from these programs may not be broadly applicable.
Healthcare Economics & Policy, Practice Management
About a quarter of those who require insulin to treat diabetes use less than what is prescribed because of cost concerns, suggests a single-center study presented last week at the American Diabetes Association scientific sessions in Orlando.
Healthcare Economics & Policy, Lipids & Metabolic
A pair of point/counterpoint articles published online June 25 in JACC: Heart Failure debated whether the Hospital Readmissions Reduction Program (HRRP) has resulted in greater mortality for heart failure patients or whether those observations stem from incomplete or misconstrued evidence.
Healthcare Economics & Policy, Practice Management, Heart Failure
After a year of soul searching and strategic review, GE announced its move today to spin off GE Healthcare into a standalone company over the next 12 to 18 months. The goal, the company said, is a leaner corporate structure with substantial reductions in debt.
Healthcare Economics & Policy
Two nonprofits in the Philadelphia area have joined forces to deliver personalized meals to Medicaid beneficiaries.
Healthcare Economics & Policy, Lipids & Metabolic, Heart Failure